Close Menu

NEW YORK – The Multiple Myeloma Research Foundation (MMRF) has launched the online CureCloud Initiative, a project that will use results from a novel liquid biopsy assay to analyze mutations in the multiple myeloma patient population.

The foundation is working with academic and commercial groups for the project to aggregate patient health data, including patient-specific mutations and drug responses, to help oncologists determine the best course of action for targeted treatment.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Dec
15
Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.